TY  - JOUR
T1  - An Overview of New Acetamide Derivatives in COX-II Inhibitors
A1  - Karam S. Atrushi
A1  - Dana M. Ameen
A1  - Faris T. Abachi
JF  - Pharmaceutical Sciences and Drug Design
JO  - Pharm Sci Drug Des
SN  - 3062-4428
Y1  - 2023
VL  - 3
IS  - 1
DO  - 10.51847/4i0ldW0c63
SP  - 20
EP  - 30
N2  - Non-steroidal anti-inflammatory drugs (NSAIDs) have long been recognized as one of the most commonly used agents. However, their adverse effects on various organs are well-documented. This review focuses on the development of acetamide derivatives that retain their anti-inflammatory effects while selectively inhibiting COX-II. Several literature sources emphasize the importance of these heterocyclic compounds in the treatment of inflammatory conditions, recognizing their therapeutic value in this pharmacological class. COX-II inhibitors, through the prodrug approach, offer a wide range of applications and have significantly contributed to drug development. Researchers have designed numerous prodrugs using acetamide molecules to improve pharmacokinetic properties, enhance sensory attributes, or optimize chemical properties. A wide array of amide derivatives, across different classes of compounds, has been identified as effective COX-II inhibitors, primarily used for conditions such as arthritis, pain, menstrual cramps, and colonic polyps, helping to alleviate symptoms such as pain, fever, swelling, and tenderness. In addition, COX-II inhibitor nanoparticles have been investigated to improve the efficacy of the treatment.
UR  - https://galaxypub.co/article/an-overview-of-new-acetamide-derivatives-in-cox-ii-inhibitors-z71n3pjudju0ifv
ER  -